China · Delayed Price · Currency is CNY CTI BioPharma Statistics
Total Valuation
SHA:603081 has a market cap or net worth of CNY 5.23 billion. The enterprise value is 6.75 billion.
| Market Cap | 5.23B |
| Enterprise Value | 6.75B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
| Earnings Date | Aug 29, 2025 |
| Ex-Dividend Date | Jul 17, 2025 |
Share Statistics
SHA:603081 has 422.50 million shares outstanding. The number of shares has decreased by -0.73% in one year.
| Current Share Class | 422.50M |
| Shares Outstanding | 422.50M |
| Shares Change (YoY) | -0.73% |
| Shares Change (QoQ) | +2.05% |
| Owned by Insiders (%) | 38.22% |
| Owned by Institutions (%) | 3.52% |
| Float | 244.19M |
Valuation Ratios
The trailing PE ratio is 78.07 and the forward PE ratio is 17.44.
| PE Ratio | 78.07 |
| Forward PE | 17.44 |
| PS Ratio | 2.84 |
| PB Ratio | 1.62 |
| P/TBV Ratio | 1.72 |
| P/FCF Ratio | 133.03 |
| P/OCF Ratio | 36.92 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 108.80, with an EV/FCF ratio of 171.68.
| EV / Earnings | 106.36 |
| EV / Sales | 3.66 |
| EV / EBITDA | 108.80 |
| EV / EBIT | n/a |
| EV / FCF | 171.68 |
Financial Position
The company has a current ratio of 1.56, with a Debt / Equity ratio of 0.73.
| Current Ratio | 1.56 |
| Quick Ratio | 1.30 |
| Debt / Equity | 0.73 |
| Debt / EBITDA | 38.09 |
| Debt / FCF | 60.10 |
| Interest Coverage | -0.08 |
Financial Efficiency
Return on equity (ROE) is 2.00% and return on invested capital (ROIC) is -0.11%.
| Return on Equity (ROE) | 2.00% |
| Return on Assets (ROA) | -0.08% |
| Return on Invested Capital (ROIC) | -0.11% |
| Return on Capital Employed (ROCE) | -0.18% |
| Revenue Per Employee | 694,433 |
| Profits Per Employee | 23,904 |
| Employee Count | 2,655 |
| Asset Turnover | 0.24 |
| Inventory Turnover | 4.40 |
Taxes
In the past 12 months, SHA:603081 has paid 33.83 million in taxes.
| Income Tax | 33.83M |
| Effective Tax Rate | 35.34% |
Stock Price Statistics
The stock price has increased by +25.00% in the last 52 weeks. The beta is 0.61, so SHA:603081's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | +25.00% |
| 50-Day Moving Average | 11.40 |
| 200-Day Moving Average | 11.67 |
| Relative Strength Index (RSI) | 53.54 |
| Average Volume (20 Days) | 36,151,350 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603081 had revenue of CNY 1.84 billion and earned 63.47 million in profits. Earnings per share was 0.16.
| Revenue | 1.84B |
| Gross Profit | 574.76M |
| Operating Income | -9.51M |
| Pretax Income | 95.73M |
| Net Income | 63.47M |
| EBITDA | 56.80M |
| EBIT | -9.51M |
| Earnings Per Share (EPS) | 0.16 |
Balance Sheet
The company has 888.95 million in cash and 2.36 billion in debt, giving a net cash position of -1.47 billion or -3.49 per share.
| Cash & Cash Equivalents | 888.95M |
| Total Debt | 2.36B |
| Net Cash | -1.47B |
| Net Cash Per Share | -3.49 |
| Equity (Book Value) | 3.24B |
| Book Value Per Share | 7.49 |
| Working Capital | 1.33B |
Cash Flow
In the last 12 months, operating cash flow was 141.69 million and capital expenditures -102.37 million, giving a free cash flow of 39.32 million.
| Operating Cash Flow | 141.69M |
| Capital Expenditures | -102.37M |
| Free Cash Flow | 39.32M |
| FCF Per Share | 0.09 |
Margins
Gross margin is 31.17%, with operating and profit margins of -0.52% and 3.44%.
| Gross Margin | 31.17% |
| Operating Margin | -0.52% |
| Pretax Margin | 5.19% |
| Profit Margin | 3.44% |
| EBITDA Margin | 3.08% |
| EBIT Margin | -0.52% |
| FCF Margin | 2.13% |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.05%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 1.05% |
| Dividend Growth (YoY) | 160.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 214.39% |
| Buyback Yield | 0.73% |
| Shareholder Yield | 1.76% |
| Earnings Yield | 1.21% |
| FCF Yield | 0.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:603081 has an Altman Z-Score of 1.38 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.38 |
| Piotroski F-Score | 6 |